Evidence map›Paper›PMID 33895633›Full record

ArticleNeuroImage. Clinical2021

Differential patterns of gray matter volumes and associated gene expression profiles in cognitively-defined Alzheimer's disease subgroups.

Colin Groot, Michel J Grothe, Shubhabrata Mukherjee, Irina Jelistratova, Iris Jansen, Anna Catharina van Loenhoud, Shannon L Risacher, Andrew J Saykin, Christine L Mac Donald, Jesse Mez and 9 more

Open access · goldAbstract read
In one paragraph

Article in NeuroImage. Clinical, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. A novel approach to resilience and its links with education and Alzheimer's disease genetics.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  9. Article
  10. Article
  11. Cognitively defined Alzheimer's dementia subgroups have distinct atrophy patterns.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024
    Article
  12. Article
  13. Alzheimer's disease heterogeneity explained by polygenic risk scores derived from brain transcriptomic profiles.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2023
    Article
  14. Article
  15. Article
  16. Article
  17. Recent update on the heterogeneity of the Alzheimer's disease spectrum.Journal of neural transmission (Vienna, Austria : 1996) · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 9 institutions in 7 countries.

Colin GrootDepartment of Neurology & Alzheimer Center, Amsterdam University Medical Center - Location VU University Medical Center, Amsterdam, The Netherlands. Electronic address: colin.groot@gmail.com.
Michel J GrotheUnidad de Trastornos del Movimiento, Servicio de Neurología y Neurofisiología Clínica, Instituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Seville, Spain; German Center for Neurodegenerative Diseases (DZNE), Rostock, Germany. Electronic address: neurosev@gmail.com.
Shubhabrata MukherjeeDepartment of Medicine, University of Washington, Seattle, WA, USA. Electronic address: smukherj@uw.edu.
Irina JelistratovaGerman Center for Neurodegenerative Diseases (DZNE), Rostock, Germany. Electronic address: irina.jelistratova@dzne.de.
Iris JansenDepartment of Complex Trait Genetics, Center for Neurogenomics and Cognitive Research, Amsterdam Neuroscience, VU University, Amsterdam, The Netherlands. Electronic address: i.e.jansen@vu.nl.
Anna Catharina van LoenhoudDepartment of Neurology & Alzheimer Center, Amsterdam University Medical Center - Location VU University Medical Center, Amsterdam, The Netherlands. Electronic address: a.vanloenhoud@amsterdamumc.nl.
Shannon L RisacherIndiana University School of Medicine, Indianapolis, IN, USA. Electronic address: srisache@iupui.edu.
Andrew J SaykinIndiana University School of Medicine, Indianapolis, IN, USA. Electronic address: asaykin@iupui.edu.
Christine L Mac DonaldNeurological Surgery, University of Washington, Seattle, WA, USA. Electronic address: cmacd@neurosurgery.washington.edu.
Jesse MezDepartment of Neurology, Boston University School of Medicine, Boston, MA, USA; Alzheimer's Disease Center, Boston University School of Medicine, MA, USA. Electronic address: jessemez@bu.edu.
Emily H TrittschuhPsychiatry & Behavioral Science, University of Washington, Seattle, WA, USA; Veterans Affairs Puget Sound Health Care System, Geriatric Research, Education, & Clinical Center, Seattle, WA, USA. Electronic address: etritt@gmail.com.
Gregor GryglewskiDepartment of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria. Electronic address: gregor.gryglewski@meduniwien.ac.at.
Rupert LanzenbergerDepartment of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria. Electronic address: rupert.lanzenberger@meduniwien.ac.at.
Yolande A L PijnenburgDepartment of Neurology & Alzheimer Center, Amsterdam University Medical Center - Location VU University Medical Center, Amsterdam, The Netherlands. Electronic address: yal.pijnenburg@amsterdamumc.nl.
Frederik BarkhofDepartment of Radiology and Nuclear Medicine, Amsterdam University Medical Center - Location VU University Medical Center, Amsterdam, The Netherlands; University College London, Institutes of Neurology & Healthcare Engineering, London, United Kingdom. Electronic address: f.barkhof@amsterdamumc.nl.
Philip ScheltensDepartment of Neurology & Alzheimer Center, Amsterdam University Medical Center - Location VU University Medical Center, Amsterdam, The Netherlands. Electronic address: p.scheltens@amsterdamumc.nl.
Wiesje M van der FlierDepartment of Neurology & Alzheimer Center, Amsterdam University Medical Center - Location VU University Medical Center, Amsterdam, The Netherlands; Epidemiology and Biostatistics, Amsterdam University Medical Center - Location VU University Medical Center, Amsterdam, The Netherlands. Electronic address: wm.vdflier@amsterdamumc.nl.
Paul K CraneDepartment of Medicine, University of Washington, Seattle, WA, USA. Electronic address: pcrane@uw.edu.
Rik OssenkoppeleDepartment of Neurology & Alzheimer Center, Amsterdam University Medical Center - Location VU University Medical Center, Amsterdam, The Netherlands; Lund University, Clinical Memory Research Unit, Lund, Sweden. Electronic address: r.ossenkoppele@amsterdamumc.nl.
Amsterdam University Medical Centers · NLUniversity of Washington · USGerman Center for Neurodegenerative Diseases · DEIndiana University School of MedicineMedical University of Vienna · ATAmsterdam Neuroscience · NLBoston University · USLund University · SEUniversity College London · GB

Funding

Improving Cognitive Outcome Precision & Responsiveness with Modern PsychometricsR01AG029672 · NIA · UNIVERSITY OF WASHINGTON · PI CRANE, PAUL K · 2007 to 2021
$7.0M
Molecular mechanisms of Alzheimer's disease neuropathological endophenotypesK25AG055620 · NIA · UNIVERSITY OF WASHINGTON · PI MUKHERJEE, SHUBHABRATA · 2018 to 2022
$653k
Genetic and Neuropsychological Heterogeneity in Alzheimer's DiseaseK23AG046377 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI MEZ, JESSE BENJAMIN · 2014 to 2018
$639k
Department of HealthNIA NIH HHS K23 AG046377NIA NIH HHS K25 AG055620NIA NIH HHS R01 AG029672
6 · The paper itself

Abstract

The clinical presentation of Alzheimer's disease (AD) varies widely across individuals but the neurobiological mechanisms underlying this heterogeneity are largely unknown. Here, we compared regional gray matter (GM) volumes and associated gene expression profiles between cognitively-defined subgroups of amyloid-β positive individuals clinically diagnosed with AD dementia (age: 66 ± 7, 47% male, MMSE: 21 ± 5). All participants underwent neuropsychological assessment with tests covering memory, executive-functioning, language and visuospatial-functioning domains. Subgroup classification was achieved using a psychometric framework that assesses which cognitive domain shows substantial relative impairment compared to the intra-individual average across domains, which yielded the following subgroups in our sample; AD-Memory (n = 41), AD-Executive (n = 117), AD-Language (n = 33), AD-Visuospatial (n = 171). We performed voxel-wise contrasts of GM volumes derived from 3Tesla structural MRI between subgroups and controls (n = 127, age 58 ± 9, 42% male, MMSE 29 ± 1), and observed that differences in regional GM volumes compared to controls closely matched the respective cognitive profiles. Specifically, we detected lower medial temporal lobe GM volumes in AD-Memory, lower fronto-parietal GM volumes in AD-Executive, asymmetric GM volumes in the temporal lobe (left < right) in AD-Language, and lower GM volumes in posterior areas in AD-Visuospatial. In order to examine possible biological drivers of these differences in regional GM volumes, we correlated subgroup-specific regional GM volumes to brain-wide gene expression profiles based on a stereotactic characterization of the transcriptional architecture of the human brain as provided by the Allen human brain atlas. Gene-set enrichment analyses revealed that variations in regional expression of genes involved in processes like mitochondrial respiration and metabolism of proteins were associated with patterns of regional GM volume across multiple subgroups. Other gene expression vs GM volume-associations were only detected in particular subgroups, e.g., genes involved in the cell cycle for AD-Memory, specific sets of genes related to protein metabolism in AD-Language, and genes associated with modification of gene expression in AD-Visuospatial. We conclude that cognitively-defined AD subgroups show neurobiological differences, and distinct biological pathways may be involved in the emergence of these differences.

Indexed as

Alzheimer DiseaseAgedAmyloid beta-PeptidesBrainFemaleGray MatterHumansMagnetic Resonance ImagingMaleMiddle AgedNeuropsychological TestsTranscriptomeAmyloid beta-PeptidesAlzheimer’s diseaseGene expressionGray matter volumesHeterogeneityPsychometrics

Identifiers

PMID33895633
PMCPMC8186562
OpenAlexW3143380785

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.